Chemoinformaics analysis of 5,6,7-TRIMETHOXY-2-(4-METHOXYPHENYL)CHROMEN-4-ONE
| Molecular Weight | 342.347 | nRot | 5 |
| Heavy Atom Molecular Weight | 324.203 | nRig | 18 |
| Exact Molecular Weight | 342.11 | nRing | 3 |
| Solubility: LogS | -4.739 | nHRing | 1 |
| Solubility: LogP | 3.425 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 48.5443 |
| nHD | 0 | BPOL | 27.6057 |
| QED | 0.707 |
| Synth | 2.151 |
| Natural Product Likeliness | 0.775 |
| NR-PPAR-gamma | 0.313 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.554 |
| MDCK | 0.000046 |
| BBB | 0.103 |
| PPB | 0.776478 |
| VDSS | 0.794 |
| FU | 0.174906 |
| CYP1A2-inh | 0.638 |
| CYP1A2-sub | 0.977 |
| CYP2c19-inh | 0.84 |
| CYP2c19-sub | 0.818 |
| CYP2c9-inh | 0.825 |
| CYP2c9-sub | 0.924 |
| CYP2d6-inh | 0.054 |
| CYP2d6-sub | 0.93 |
| CYP3a4-inh | 0.666 |
| CYP3a4-sub | 0.675 |
| CL | 4.567 |
| T12 | 0.251 |
| hERG | 0.3 |
| Ames | 0.519 |
| ROA | 0.131 |
| SkinSen | 0.475 |
| Carcinogencity | 0.068 |
| EI | 0.174 |
| Respiratory | 0.236 |
| NR-Aromatase | 0.842 |
| Antiviral | Yes |
| Prediction | 0.791246 |